Al-Rajabi R - Search Results

1

A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.

Kasi A, Gaudel P, Lekkala M, Al-Rajabi R, Saeed A, Sun W, Porter C. Kasi A, et al. J Oncol Pharm Pract. 2023 Dec;29(8):1951-1956. doi: 10.1177/10781552231161822. Epub 2023 Mar 7. J Oncol Pharm Pract. 2023. PMID: 36883259

2

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.

Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.

3

Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction.

Al-Rajabi R, Patel S, Ketchum NS, Jaime NA, Lu TW, Pollock BH, Mahalingam D. Al-Rajabi R, et al. J Gastrointest Oncol. 2015 Jun;6(3):259-67. doi: 10.3978/j.issn.2078-6891.2015.005. J Gastrointest Oncol. 2015. PMID: 26029452 Free PMC article.

4

Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma.

Saeed A, Park R, Al-Jumayli M, Al-Rajabi R, Sun W. Saeed A, et al. Clin Colorectal Cancer. 2019 Jun;18(2):81-90. doi: 10.1016/j.clcc.2019.02.005. Epub 2019 Feb 27. Clin Colorectal Cancer. 2019. PMID: 30905548 Review.

5

Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.

Al-Jumayli M, Batool A, Middiniti A, Saeed A, Sun W, Al-Rajabi R, Baranda J, Kumer S, Schmitt T, Chidharla A, Kasi A. Al-Jumayli M, et al. J Oncol. 2019 May 2;2019:3293509. doi: 10.1155/2019/3293509. eCollection 2019. J Oncol. 2019. PMID: 31186632 Free PMC article.

6

Controversies in Rectal Cancer Treatment and Management.

Sun W, Al-Rajabi R, Perez RO, Abbasi S, Ash R, Habr-Gama A. Sun W, et al. Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-11. doi: 10.1200/EDBK_279871. Am Soc Clin Oncol Educ Book. 2020. PMID: 32239978 Free article. Review.

7

Mohyuddin GR, Aziz M, Britt A, Wade L, Sun W, Baranda J, Al-Rajabi R, Saeed A, Kasi A. Mohyuddin GR, et al. BMC Cancer. 2020 Jun 3;20(1):507. doi: 10.1186/s12885-020-06948-5. BMC Cancer. 2020. PMID: 32493233 Free PMC article.

8

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study.

Saeed A, Hildebrand H, Park R, Al-Jumayli M, Abbasi S, Melancon T, Saeed A, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Sun W. Saeed A, et al. J Clin Med. 2020 Aug 19;9(9):2682. doi: 10.3390/jcm9092682. J Clin Med. 2020. PMID: 32824968 Free PMC article.

9

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer.

Allen J, Cernik C, Bajwa S, Al-Rajabi R, Saeed A, Baranda J, Williamson S, Sun W, Kasi A. Allen J, et al. J Clin Med. 2020 Oct 13;9(10):3283. doi: 10.3390/jcm9103283. J Clin Med. 2020. PMID: 33066235 Free PMC article.

10

Dual deficiency of DPD and UGT1A1 in a case of colon cancer.

Rawlley B, Diab O, Al-Rajabi R, Carroll E, Melancon T, Kasi A. Rawlley B, et al. Pharmacogenomics. 2020 Dec;21(18):1265-1269. doi: 10.2217/pgs-2020-0097. Epub 2020 Nov 18. Pharmacogenomics. 2020. PMID: 33203301 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters